Shed vs MedVi: Coaching, meds, price and support compared
Shed vs MedVi boils down to whether you want integrated coaching and name-brand options or a lower promotional entry point for compounded semaglutide. Early verdict: choose Shed if you want both name-brand and compounded GLP-1 plus continuous coaching; choose MedVi if your priority is a low first-month price and a fully online, no-clinic process.
Explore Shed plans and coaching
How the two providers differ at a glance
This direct comparison focuses on the most distinctive differences supported by the source: medication breadth, pricing and promotions, coaching and support, and the enrollment process and shipping. Both platforms prescribe after clinician review and both offer compounded medication options, but their emphases and price structures diverge.
Medication options: name-brand plus compounds versus compounded semaglutide only
Shed offers both FDA-approved name-brand GLP-1s and compounded alternatives on one platform, explicitly letting patients choose based on budget and preference. The source notes that name-brand options carry higher costs while compounded options are more affordable. MedVi, by contrast, offers clinically dosed compounded semaglutide only; the source states MedVi does not offer branded options and focuses on compounded semaglutide.
See MedVi compounded semaglutide pricing
Pricing and promotions
Shed lists compounded semaglutide starting at $199/month and compounded tirzepatide starting at $299/month, and advertises 10% off your first month. Shed does not publish a single standard price and gives personalized quotes after intake. MedVi advertises a promotional first month at $179 including fast, free shipping, with ongoing standalone months at $299 and a three-month plan at $649 as noted in the source. The source warns MedVi’s ongoing price is substantially higher than the first-month promo.
Coaching and support
Shed integrates continuous coaching into treatment and positions coaching as part of the bundled monthly cost. The source frames Shed as a platform for patients who want behavioral support alongside medication. MedVi emphasizes 24/7 support from certified medical professionals and a simple online process; the source highlights MedVi’s clinically dosed compounded semaglutide plus round the clock support, but it does not describe an integrated coaching membership equivalent to Shed’s coaching model.
Start Shed 2-minute assessment
Enrollment process, clinic visits and shipping
MedVi’s process is entirely online with no clinic visits required, and the landing evidence states fast, free shipping is included in the promotional first month. Shed uses a 2-minute online assessment to check eligibility and requires a licensed clinician to confirm treatment; medication is shipped after clinician review. Both platforms rely on clinician review before prescriptions are issued and both note that compounded medications are not FDA-approved.
Quick comparison table
| Criteria | Shed | MedVi |
|---|---|---|
| Medication types | Name-brand and compounded GLP-1 options | Compounded semaglutide only |
| Starting price | Compounded semaglutide starting at $199/month; compounded tirzepatide starting at $299/month; personalized quote | Promotional first month $179 with fast, free shipping; then higher ongoing rates |
| Coaching and support | Continuous coaching integrated into treatment | 24/7 support from certified medical professionals |
| Process | 2-minute assessment then clinician review; medication shipped if appropriate | Simple online intake, no clinic visits; clinician review then shipment |
| Regulatory note | Compounded medications not FDA-approved | Compounded medications not FDA-approved |
Other important provider distinctions
- Shed highlights flexibility to choose medication type based on budget and needs and warns that name-brand options are costlier.
- MedVi highlights a low first-month promo and emphasizes a no-clinic, fully online experience with free shipping for the promotional month.
- Both platforms require a licensed clinician to determine if treatment is appropriate and both note results may vary.
Safety and regulatory language
Both sources state compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness, or quality. Each platform says prescriptions are issued only after a clinician review and that results may vary. MedVi also notes patient-reported data and that medication is provided by affiliated medical networks; Shed directs readers to Terms and Conditions for details on guarantees and outcomes.
Check MedVi enrollment details
Conclusion and who should choose which
For a direct decision using the primary keyword Shed vs MedVi: if you value both name-brand and compounded GLP-1 options plus continuous coaching integrated into treatment, Shed is the stronger fit based on the source. If you want the lowest promotional first-month price and a fully online, no-clinic process for compounded semaglutide with fast, free shipping, MedVi is the clearer match.
Choose Shed if you want name-brand plus compounded GLP-1 options, integrated coaching, and a fast 2-minute assessment with a personalized quote.
Choose MedVi if you want a low first-month promotional rate for compounded semaglutide, a simple online intake with no clinic visits, and fast, free shipping for the promo month.